Current Tropical Medicine Reports

, Volume 5, Issue 2, pp 67–76 | Cite as

Cutaneous Tuberculosis: a Review of the Current Literature

  • Andrés Tirado-Sánchez
  • Alexandro Bonifaz
Cutaneous Mycobacterial Diseases of the Skin and Soft Tissues (C Franco-Paredes, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Cutaneous Mycobacterial Diseases of the Skin and Soft Tissues


Purpose of review

This review summarizes the literature currently available for cutaneous tuberculosis (CTB), as well as providing data for clinical utility.

Recent findings

Available studies in CTB are scarce; however, they provide important information about efficacy and outcome in clinical practice.


We can detect differences in the clinical aspect and disease evolution; this is due to the individual immunity, environmental factors, and the type of inoculum. Treatment options for CTB are currently limited to the conventional oral therapy and the occasional surgical intervention in cases where needed. The development of multidrug-resistant strains and extremely resistant to drugs has also threatened treatment effectiveness. The aim of the article is to review the current status of CTB, in addition to a better knowledge of the molecular and cellular mechanisms regulating host-agent interaction.


Mycobacterium tuberculosis Tuberculosis Cutaneous tuberculosis 


Compliance with Ethical Standards

Conflict of Interest

Andrés Tirado-Sánchez and Alexandro Bonifaz declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Nadjane Batista Lacerda S, Cristina de Abreu Temoteo R, Maria Ribeiro Monteiro de Figueiredo T, Darliane Tavares de Luna F, Alves Nunes de Sousa M, Carlos de Abreu L, et al. Individual and social vulnerabilities upon acquiring tuberculosis: a literature systematic review. Int Arch Med. 2014;7:35.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    • Dias MF, Bernardes Filho F, Quaresma MV, Nascimento LV, Nery JA, Azulay DR. Update on cutaneous tuberculosis. An Bras Dermatol. 2014;89(6):925–38. This paper includes an overview of the disease.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    • van Zyl L, du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment regimens. Tuberculosis (Edinb). 2015;95(6):629–38. This paper includes an overview of the disease.CrossRefGoogle Scholar
  4. 4.
    Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. 2nd ed. Geneva: World Health Organization; 2014.Google Scholar
  5. 5.
    • Melsew YA, Doan TN, Gambhir M, Cheng AC, McBryde E, Trauer JM. Risk factors for infectiousness of patients with tuberculosis: a systematic review and meta-analysis. Epidemiol Infect. 2018;1-9. This paper shows a summary of the most commonly seen risk factors for tuberculosis.Google Scholar
  6. 6.
    Mwiru RS, Nagu TJ, Kaduri P, Fawzi W, Mugusi F. Prevalence and factors associated with alcohol drinking among HIV and tuberculosis co-infected patients in Dar es Salaam, Tanzania. AIDS Care. 2018;30(2):173–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Nakiwala JK, Walker NF, Diedrich CR, Worodria W, Meintjes G, Wilkinson RJ, et al. Neutrophil activation and enhanced release of granule products in HIV-TB immune reconstitution inflammatory syndrome. J Acquir Immune Defic Syndr. 2018;77(2):221–9.PubMedGoogle Scholar
  8. 8.
    GBD. 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1151–210.CrossRefGoogle Scholar
  9. 9.
    •• Bainomugisa A, Lavu E, Hiashiri S, Majumdar S, Honjepari A, Moke R, et al. Multi-clonal evolution of multi-drug-resistant/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over three decades. Microb Genom. 2018; This paper gives important clues for the mechanisms of drug-resistance in tuberculosis.
  10. 10.
    Zhu B, Dockrell HM, Ottenhoff THM, Evans TG, Zhang Y. Tuberculosis vaccines: opportunities and challenges. Respirology. 2018;23:359–68. Scholar
  11. 11.
    Baek SO, Ko HS, Han HH. BCG vaccination-induced suppurative lymphadenitis: four signs to pay attention to. Int Wound J. 2017;14(6):1385–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Sehgal VN, Gupta RP, Karmakar S, Logani KB, Jain S. In situ characterization of lymphocytic immunophenotypes and interleukin-2 receptors in cutaneous tuberculosis and leprosy--a comparative evaluation. Clin Exp Dermatol. 1994;19(4):312–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Bell LCK, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nat Rev Microbiol. 2018;16(2):80–90.CrossRefPubMedGoogle Scholar
  14. 14.
    Parlato S, Chiacchio T, Salerno D, Petrone L, Castiello L, Romagnoli G, et al. Impaired IFN-α-mediated signal in dendritic cells differentiates active from latent tuberculosis. PLoS One. 2018;13(1):e0189477.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Kennedy AE, O'Mahony J, Byrne N, MacSharry J, Sayers RG. Is TB testing associated with increased blood interferon-gamma levels? Front Vet Sci. 2017;4:176.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Ramaraj SM, Nagendra K, Gopal G, Majgi SM. Need for different cutoff values for reading mantoux test with 2TU and 5TU PPD. Indian J Pediatr. 2017;84(9):677–80.CrossRefPubMedGoogle Scholar
  17. 17.
    Marín D, Marín N, Del Corral H, López L, Ramirez-Agudelo ME, Rojas CA, et al. PPD-induced monocyte mitochondrial damage is associated with a protective effect to develop tuberculosis in BCG vaccinated individuals: a cohort study. PLoS One. 2017;12(2):e0171930.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    •• Hill MK, Sanders CV. Cutaneous tuberculosis. Microbiol Spectr. 2017;5(1) This paper gives important strategies for treating cutaneous tuberculosis.
  19. 19.
    • Scollard DM, Dacso MM, Abad-Venida ML. Tuberculosis and leprosy: classical granulomatous diseases in the twenty-first century. Dermatol Clin. 2015;33(3):541–62. This paper gives a complete review of leprosy and tuberculosis.CrossRefPubMedGoogle Scholar
  20. 20.
    Micali G, Lacarrubba F, Massimino D, Schwartz RA. Dermatoscopy: alternative uses in daily clinical practice. J Am Acad Dermatol. 2011;64(6):1135–46.CrossRefPubMedGoogle Scholar
  21. 21.
    •• Chakrabortty R, Rahman MA, Ferdousi KR, Paul BK. Cutaneous tuberculosis: an update. Mymensingh Med J. 2016;25(2):385–91. An important review of the disease focusing on therapeutic options.PubMedGoogle Scholar
  22. 22.
    Braun-Falco O, Thomas P. The tuberculid concept from the current viewpoint. Hautarzt. 1995;46(6):383–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Hallensleben ND, de Vries HJ, Lettinga KD, Scherpbier HJ. Tuberculids: cutaneous indicator diseases of Mycobacterium tuberculosis infection in young patients. J Eur Acad Dermatol Venereol. 2016;30(9):1590–3.CrossRefPubMedGoogle Scholar
  24. 24.
    Suárez Castañón C, Pérez Méndez C, Alvarez Cuesta CC, Corrales Canel B, Blanco Costa MI. Erythema induratum of Bazin associated to Mycobacterium tuberculosis infection. Arch Argent Pediatr. 2012;110(3):e43–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Boortalary T, Misra K, McNish S, Jones D, Shanmugam VK. Prevalence of positive QuantiFERON gold in-tube testing in Hidradenitis suppurativa. J Dermatolog Treat 2018;1–16.Google Scholar
  26. 26.
    Matono T, Nishijima T, Teruya K, Morino E, Takasaki J, Gatanaga H, et al. Substantially higher and earlier occurrence of anti-tuberculosis drug-related adverse reactions in HIV coinfected tuberculosis patients: a matched-cohort study. AIDS Patient Care STDs. 2017;31(11):455–62.CrossRefPubMedGoogle Scholar
  27. 27.
    Yoshioka Y, Hanafusa T, Namiki T, Nojima K, Amano M, Tokoro S, et al. Drug-induced hypersensitivity syndrome by ethambutol: a case report. J Dermatol. 2016;43(8):971–2.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Dermatology DepartmentHospital General de México “Dr. Eduardo Liceaga”Mexico CityMexico
  2. 2.Dermatology DepartmentInstituto Mexicano del Seguro SocialMexico CityMexico

Personalised recommendations